Meet the MedCity Media Team

And take 2 minutes to help us make MedCityNews.com better for you.

Every year, we ask you to tell us a little about yourself (anonymously) to help us create better, more relevant content and features for you. We consider every response and very much appreciate you taking the time to assist us.

Please click the button above to open a simple, multiple choice survey that should only take 2 minutes to complete.

Thank you,

The MedCity Media Team

Still waiting on FDA to approve medical device identifiers (big sigh)

1:21 pm by | 0 Comments

FDA logoWhile the FDA promised decisions on unique identifiers by the end of June, according to Modern Healthcare, it’s still under “administrative review.”

The FDA has received an open letter to the Office of Management and Budget urging them to push the regulations through and to shorten its proposed seven-year time frame from the Advancing Patient Safety Coalition. In an odd marriage, The Pew Charitable Trusts and Premier healthcare alliance also sent an open letter, emphasizing a “prompt” complete review. Both letters were sent last week.

According to Modern Healthcare:

“Congress passed a 2007 law first mandating the development of the unique-device identification system. A law passed last year required the final rule to be released within six months of the closing of the comment period for the proposed rule.

The FDA has proposed a risk-based approach to the roll-out of the UDI system, starting with the packaging of high-risk medical devices and eventually including low-risk devices over a seven-year period.”

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Lindsey Alexander

By Lindsey Alexander

Lindsey Alexander is an Indiana-based freelance writer and editor covering the medical device industry. She earned a degree in journalism from Indiana University and a master's from Purdue.
Visit website | More posts by Author

0 comments

Hear the latest news first

Get our daily newsletter or follow us.

 

Advertisement